• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyridazines and derivatives

Introduction to 6-Methylpyridazine-3-carboxylic acid (CAS No. 64210-60-2)

6-Methylpyridazine-3-carboxylic acid, identified by the Chemical Abstracts Service registry number 64210-60-2, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyridazine class, characterized by a six-membered aromatic ring containing two adjacent nitrogen atoms. The presence of a methyl group at the 6-position and a carboxylic acid functional group at the 3-position imparts unique chemical and pharmacological properties, making it a valuable scaffold for the development of novel bioactive molecules.

The structural features of 6-Methylpyridazine-3-carboxylic acid contribute to its potential as a pharmacophore in drug discovery. The pyridazine core is a versatile platform that has been extensively explored for its biological activity. It is particularly recognized for its role in modulating various biological pathways, including enzyme inhibition and receptor binding. The carboxylic acid moiety further enhances its reactivity, allowing for facile derivatization through esterification, amidation, or other chemical transformations, which can fine-tune its pharmacokinetic and pharmacodynamic properties.

In recent years, there has been growing interest in pyridazine derivatives due to their demonstrated efficacy in treating a range of therapeutic conditions. For instance, studies have highlighted the potential of substituted pyridazines as inhibitors of enzymes involved in inflammation and metabolic disorders. The methyl group at the 6-position of 6-Methylpyridazine-3-carboxylic acid plays a crucial role in determining its binding affinity and selectivity, which are critical factors in drug design. This modification can influence the compound's interactions with biological targets, thereby affecting its overall biological activity.

One of the most compelling aspects of 6-Methylpyridazine-3-carboxylic acid is its versatility as a building block for more complex molecules. Researchers have leveraged this compound to synthesize derivatives with enhanced potency and improved pharmacological profiles. For example, recent studies have demonstrated that incorporating additional functional groups into the pyridazine ring can lead to compounds with improved solubility and bioavailability. These advancements underscore the importance of 6-Methylpyridazine-3-carboxylic acid in medicinal chemistry and highlight its potential as a precursor for next-generation therapeutics.

The synthesis of 6-Methylpyridazine-3-carboxylic acid typically involves multi-step organic reactions that require precise control over reaction conditions. Common synthetic routes include condensation reactions between appropriate precursors, followed by functional group transformations such as oxidation or reduction. The exact methodology can vary depending on the desired purity and scale of production, but modern synthetic techniques have greatly improved the efficiency and yield of these processes. This accessibility makes 6-Methylpyridazine-3-carboxylic acid an attractive candidate for both academic research and industrial applications.

From a computational chemistry perspective, 6-Methylpyridazine-3-carboxylic acid has been extensively studied to understand its molecular interactions and binding modes. Molecular docking simulations have revealed that this compound can bind to various biological targets with high affinity, suggesting its potential as an inhibitor or modulator of enzyme activity. These computational studies not only provide insights into the mechanistic basis of its biological effects but also aid in the rational design of more potent derivatives.

The pharmacological evaluation of 6-Methylpyridazine-3-carboxylic acid has shown promising results in preclinical models. In vitro assays have demonstrated its ability to modulate key signaling pathways associated with diseases such as cancer, diabetes, and neurodegenerative disorders. While these findings are encouraging, further research is needed to fully elucidate its therapeutic potential and safety profile. Ongoing clinical trials are expected to provide more comprehensive data on its efficacy and tolerability in human populations.

The future prospects for 6-Methylpyridazine-3-carboxylic acid are vast, particularly as drug discovery continues to evolve at an unprecedented pace. Advances in synthetic chemistry, computational modeling, and high-throughput screening technologies are likely to unlock new opportunities for developing derivatives with enhanced therapeutic properties. Moreover, interdisciplinary collaborations between chemists, biologists, and clinicians will be essential in translating basic research findings into tangible medical breakthroughs.

In conclusion,6-Methylpyridazine-3-carboxylic acid (CAS No. 64210-60-2) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and versatile reactivity. Its potential as a pharmacophore has been recognized through numerous studies exploring its biological activity and synthetic applications. As research continues to uncover new insights into this compound's properties,6-Methylpyridazine-3-carboxylic acid is poised to play a crucial role in the development of innovative therapies for a wide range of diseases.

• 303180-11-2(1H-pyrazole-3,5-dicarboxylic acid;hydrate)
• 3112-31-0(1H-Pyrazole-3,5-dicarboxylic acid)
• 106584-51-4(Methyl 6-methylpyridazine-3-carboxylate)
• 402-61-9(AS057278)
• 1621-91-6(1H-pyrazole-5-carboxylic acid)
• 217447-50-2(3-Pyridazinecarboxylicacid, 2,3,4,5-tetrahydro-4-hydroxy-, methyl ester, (3R,4R)-)
• 797027-83-9(1H-Pyrazole-3-carboxylicacid)
• 2164-61-6(Pyridazine-3-carboxylic acid)
• 57266-70-3(H2DCP)
• 696-22-0(3-Methyl-1H-pyrazole-5-carboxylic acid)